VeriMomБезопасен ли dea-lauraminopropionate при беременности?
No harmonised reproductive classification or SCCS/CIR safety assessment specific to DEA‑lauraminopropionate was found; CIR/industry documents treat DEA‑type ingredients as a class of interest but do not assign a reproductive hazard to this specific salt. However, diethanolamine (DEA) itself has shown developmental/neurodevelopmental effects in animal studies (mouse dermal study), so a theoretical mechanism exists via the DEA moiety (choline/metabolic interference) though no direct reproductive data for this specific INCI were located. (Sources: CIR mentions DEA family; animal study: Dose‑response dermal DEA mouse study.)
Related ingredients
Frequently asked questions
- Безопасен ли dea-lauraminopropionate при беременности?
- No harmonised reproductive classification or SCCS/CIR safety assessment specific to DEA‑lauraminopropionate was found; CIR/industry documents treat DEA‑type ingredients as a class of interest but do not assign a reproductive hazard to this specific salt. However, diethanolamine (DEA) itself has shown developmental/neurodevelopmental effects in animal studies (mouse dermal study), so a theoretical mechanism exists via the DEA moiety (choline/metabolic interference) though no direct reproductive data for this specific INCI were located. (Sources: CIR mentions DEA family; animal study: Dose‑response dermal DEA mouse study.)
- Безопасен ли dea-lauraminopropionate при грудном вскармливании?
- No data indicate DEA‑lauraminopropionate is classified as a reproductive or lactation hazard; breastfeeding risk would be driven by maternal systemic absorption of DEA moiety, for which no human milk transfer data were identified. Theoretical mechanistic concern derives from DEA animal data, but there is no product‑specific evidence showing transfer into breast milk. (Sources: CIR / DEA literature; PubMed animal study.)
- Безопасен ли dea-lauraminopropionate для кожи малыша?
- There are no infant‑specific toxicity or classification data for DEA‑lauraminopropionate. Following conservative exposure considerations, measurable dermal absorption in adults (low) is expected to be higher in infants because of immature skin and higher surface‑area‑to‑body‑weight, so exposure score is increased by +1; hazard remains based on absence of direct evidence for this compound and reliance on theoretical concern from the DEA moiety. (Sources: regulatory INCI listings; DEA animal data.)
- Как VeriMom оценивает dea-lauraminopropionate?
- VeriMom оценивает dea-lauraminopropionate в 87/100 (низкий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы dea-lauraminopropionate при беременности?
- См. наш список безопасных альтернатив dea-lauraminopropionate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.